长切割性骨肉瘤 - 一个单一中心的经验
Geetha Narayanan1, Sugeeth M Thambi1, Jayasree Kattoor2
1Department of Medical Oncology, Regional Cancer Centre, Trivandrum, Kerala, India.
South Asian journal of cancer
|December 31, 2025
概括
长管性骨肉瘤是一种罕见的骨癌,在多模式治疗中显示出有前途的结果. 用化疗和手术治疗的患者实现了缓解,这表明对这种骨髓瘤亚型的有效管理策略.
科学领域:
- 在瘤学瘤学.
- 整形瘤学 整形瘤学
- 癌症研究 癌症研究
背景情况:
- 长管性骨肉瘤是一种罕见的亚型,占骨肉瘤病例的不到4%.
- 它具有独特的放射和病理特征,经常模仿动脉瘤骨囊.
- 了解其临床特征和治疗结果对于改善患者预后至关重要.
研究的目的:
- 为了研究telangiectatic骨髓瘤患者的临床特征.
- 为了评估被诊断为telangiectatic骨髓瘤的患者的治疗结果.
- 分析治疗后的生存率和缓解状态.
主要方法:
- 在12年内对13名被诊断患有电脉切割性骨肉瘤的患者进行了回顾性分析.
- 患者接受了新辅助和/或辅助化疗 (伊福斯法米德,多克索鲁比辛,西斯丁).
- 治疗包括节约四肢的手术或截肢.
主要成果:
- 呈现时的平均年龄为20岁,男性占主导地位.
- 常见的部位是股骨下部和骨上部.
- 在接受治疗的10名患者中,有8名患者实现了缓解,随访时间中位数为50个月.
结论:
- 长管性骨肉瘤,尽管很少见,但可以有效地通过化学疗法和手术的结合来管理.
- 观察到的缓解率表明,在当前的治疗方案下,预后有利.
- 进一步研究优化治疗这种特定的骨髓瘤亚型是有必要的.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...